Sei Investments Co. purchased a new position in shares of Oak Street Health, Inc. (NYSE:OSH) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 15,449 shares of the company’s stock, valued at approximately $826,000.
Several other hedge funds also recently bought and sold shares of the company. Manchester Capital Management LLC bought a new position in shares of Oak Street Health in the 3rd quarter valued at about $28,000. Jane Street Group LLC bought a new stake in Oak Street Health during the third quarter valued at $238,000. Treasurer of the State of North Carolina bought a new stake in Oak Street Health during the third quarter valued at $338,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Oak Street Health in the 3rd quarter worth about $358,000. Finally, Charles Schwab Investment Management Inc. purchased a new stake in Oak Street Health in the 3rd quarter valued at about $686,000.
Several analysts have recently weighed in on OSH shares. SVB Leerink raised their price objective on shares of Oak Street Health from $55.00 to $78.00 and gave the company an “outperform” rating in a research report on Wednesday, November 11th. Zacks Investment Research upgraded shares of Oak Street Health from a “sell” rating to a “hold” rating in a research report on Saturday, November 14th. ValuEngine cut shares of Oak Street Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 16th. Robert W. Baird raised their target price on shares of Oak Street Health from $55.00 to $60.00 and gave the stock an “outperform” rating in a report on Wednesday, November 11th. Finally, Morgan Stanley raised shares of Oak Street Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $50.00 to $64.00 in a research report on Thursday, December 17th. One analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $64.50.
Oak Street Health (NYSE:OSH) last posted its earnings results on Monday, November 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.15). The firm had revenue of $217.90 million during the quarter, compared to analyst estimates of $213.00 million. The company’s quarterly revenue was up 56.6% on a year-over-year basis. Research analysts anticipate that Oak Street Health, Inc. will post -0.56 earnings per share for the current year.
In related news, insider Griffin Myers sold 459,750 shares of the business’s stock in a transaction on Monday, December 7th. The shares were sold at an average price of $46.00, for a total value of $21,148,500.00. Following the completion of the sale, the insider now owns 48 shares of the company’s stock, valued at approximately $2,208. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Geoffrey M. Price sold 469,750 shares of the business’s stock in a transaction on Monday, December 7th. The stock was sold at an average price of $46.00, for a total transaction of $21,608,500.00. Following the completion of the sale, the chief operating officer now directly owns 7,510,287 shares of the company’s stock, valued at approximately $345,473,202. The disclosure for this sale can be found here. In the last three months, insiders sold 1,474,250 shares of company stock valued at $67,815,500. 5.66% of the stock is owned by insiders.
Oak Street Health Company Profile
Oak Street Health, Inc, through its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of September 30, 2020, it operated 67 centers in Illinois, Indiana, Michigan, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.